Ginza Phoenix Clinic: Highly Active NK Cell and Immune Checkpoint Combined Therapy

Director ginza

Located in the UDX Building in Chiyoda-ku, Tokyo, Ginza Phoenix Clinic is a high-end clinic specializing in regenerative medicine and immuno-oncology. Guided by Director Tetsuyuki Hirahata, the clinic is dedicated to applying advanced immune defense reconstruction technologies to anti-cancer practice.

NK Cell Combination with Immune Checkpoint Inhibitors: This is a core advantage. Based on the patient's condition, Opdivo or Keytruda is used with high-activity NK cells. This "combination therapy" unmasks cancer cells and boosts immune attacks, offering a new turning point for refractory cancers.

Core Features and Technologies

1. Highly Active NK Cell Therapy: Holds Category II Regenerative Medicine certification from the MHLW. NK cells expanded through patented technology are significantly superior in both number and activity compared to traditional methods.
2. Immune Checkpoint Inhibitor Combinations: Based on the patient's current condition, physicians flexibly use Opdivo (Nivolumab) or Keytruda (Pembrolizumab) in combination with cell therapy to achieve synergistic anti-cancer effects.
3. Refined Personal Care: The clinic provides a quiet and private environment with detailed one-on-one consultations, allowing patients to receive advanced and warm nurturing care in a comfortable atmosphere.

【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).